Dogwood plans to raise about $5 million for working capital by issuing 4.1 million shares to an existing holder. The cash could help the company, but the added shares give current owners a smaller portion, so the filing does not shift the outlook.
The planned cash is meant for working capital, which could help pay company costs. The extra shares would give current owners a smaller share of Dogwood. Since the filing describes both and says the sale has not closed, it does not point clearly in either direction.
Follow Dogwood Therapeutics, Inc. (DWTX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for DWTX